Short Interest in MDxHealth Surges 88.5%

Shares sold short reach 73,632, representing 0.2% of the company's stock.

Apr. 13, 2026 at 8:49am

Got story updates? Submit your updates here. ›

An extreme close-up of industrial banking machinery and components, conveying a sense of financial security and institutional wealth without using literal currency or charts.The surge in short interest for MDxHealth reflects growing investor skepticism about the company's near-term prospects.Newton Today

MDxHealth SA (NASDAQ:MDXH), a molecular diagnostics company focused on cancer testing, saw a significant increase in short interest during March. The number of shares sold short grew 88.5% to 73,632, representing 0.2% of the company's total shares outstanding.

Why it matters

The rise in short interest indicates increased investor skepticism about MDxHealth's near-term performance and growth prospects, which could put downward pressure on the stock price if the trend continues.

The details

As of March 31st, MDxHealth had 73,632 shares sold short, up from 39,057 shares on March 15th. Based on the company's average daily trading volume of 214,324 shares, the current short interest ratio is 0.3 days, meaning it would take less than a day for short sellers to cover their positions.

  • As of March 31st, 2026, MDxHealth had 73,632 shares sold short.
  • On March 15th, 2026, MDxHealth had 39,057 shares sold short.

The players

MDxHealth SA

A molecular diagnostics company focused on improving cancer diagnosis and treatment through epigenetic biomarker assays.

Got photos? Submit your photos here. ›

The takeaway

The surge in short interest for MDxHealth suggests growing investor skepticism about the company's near-term prospects, which could put pressure on the stock price if the trend continues. Analysts will be closely watching the company's performance and any changes in short interest in the coming months.